High level of serum AMBP is associated with poor response to paclitaxel-capecitabine chemotherapy in advanced gastric cancer patients. (Q53247758)

12 May 2018

title

High level of serum AMBP is associated with poor response to paclitaxel-capecitabine chemotherapy in advanced gastric cancer patients. (English)

1 reference

12 May 2018

1 reference

Hao Huang

1

1 reference

12 May 2018

Yong Han

2

1 reference

12 May 2018

Jing Gao

3

1 reference

12 May 2018

Junnan Feng

4

1 reference

12 May 2018

Lei Zhu

5

1 reference

12 May 2018

Like Qu

6

1 reference

12 May 2018

Lin Shen

7

1 reference

12 May 2018

Chengchao Shou

8

1 reference

12 May 2018

publication date

18 October 2013

1 reference

12 May 2018

published in

Medical Oncology

1 reference

12 May 2018

volume

30

1 reference

12 May 2018

issue

4

1 reference

12 May 2018

page(s)

748

1 reference

12 May 2018

Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Impact of extended lymphadenectomy on morbidity, mortality, recurrence and 5-year survival after gastrectomy for cancer. Meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Upregulation of soluble resistance-related calcium-binding protein (sorcin) in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Quantitative proteomics for cancer biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Legumain: a biomarker for diagnosis and prognosis of human ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

The potential role of ORM2 in the development of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Quantitative proteomics reveals the temperature-dependent proteins encoded by a series of cluster genes in thermoanaerobacter tengcongensis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Drug resistance: challenges to effective therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Systemic therapy for advanced gastric cancer: a clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Recent advances in chemotherapy for advanced gastric cancer in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Sample solublization buffers for two-dimensional electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Hybridization of pulsed-Q dissociation and collision-activated dissociation in linear ion trap mass spectrometer for iTRAQ quantitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

alpha(1)-Microglobulin: a yellow-brown lipocalin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Pathological conditions involving extracellular hemoglobin: molecular mechanisms, clinical significance, and novel therapeutic opportunities for α(1)-microglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Bikunin--not just a plasma proteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Upregulation of plasma C9 protein in gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

ITIH3 is a potential biomarker for early detection of gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Towards a knowledge-based Human Protein Atlas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0748-8

Correlation between tumor response to first-line chemotherapy and prognosis in advanced gastric cancer patients

21 January 2018

1 reference

12 December 2020

Optimising treatment regimens for the management of advanced gastric cancer

1 reference

12 December 2020

Gastric cancer epidemiology and risk factors

1 reference

12 December 2020

Impact of clinical response to first-line chemotherapy on gastric cancer patients treated with second-line and third-line chemotherapy

1 reference

12 December 2020

10.1007/S12032-013-0748-8

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018